Safe drug

Effective and safe drug therapy for newborns, infants, and children depends on knowledge of pediatric pharmacokinetics and pharmacodynamics and knowledge of the drug formulation and delivery issues specific to this population. 

In conclusion, Gdm complexes currently used as MRI contrast agents can be considered as safe drugs, due to their high thermodynamic stability, kinetic inertness as well as to an efficient excretion from the body. Nevertheless, in case of renal impairment, the stability issues become much more important and macrocyclic chelates, which have considerably higher kinetic inertness, should be used instead of linear complexes. We should... 

Because bioanalytical methods constantly improve, development scientists ability to find impurities increases. The cycle could go on forever, and a drug may never be considered truly pure. Developers must strike a balance between creating a process that is far too complex and expensive (both for the manufacturer and ultimately for the patients) and one that will produce a safe drug. 

One baffling discrepancy I encountered, as I reviewed everything I could find on BZ, pertains to its safety margin. There is plenty of dissent, even outrage, about the use of BZ, but at the same time, it is sometimes described as a very safe drug. In one table, the lethal dose by injection is 40x the incapacitating dose. This is the figure I published as an estimate, based on several indirect lines of evidence. 

FDA) for use in humans to treat malaria because this drug is considered a safe drug with few side effects.These features prompted various scientists around the world to evaluate the potential of artemisinin (1) and derivatives to control cancer cells proliferation. This chapter reviews the recent advances on analytical methods for extraction and quantification of artemisinin (1) from A. annua. Examples of artemisinin-derivatives with antiproliferative activities are listed, describing the structure-activity relationships of 96 compounds. This knowledge is essential for future development and use of artemisinin derivatives in cancer therapy. The mechanism of action of artemisinin and derivatives on cancer cells have been well reviewed in literature and therefore is not discussed in this chapter. 

There was a time not long ago when researchers were united in the behef that potent, selective kinase inhibition was crucial for the development of safe drugs and that it would be very difficult, if not impossible, to achieve. Conventional wisdom held that the high concentration of cytosoHc ATP (in the milHmolar range) precluded the identification of nanomolar ATP-competitive kinase inhibitors in cell-based assays. Some of these beliefs were grounded... 

The people who care most about pharmacovigilance results are patients. They want to use the most effective and safe drugs available. Many patients would like to believe that their prescribed or OTC drug is totally safe. Many patients seek and are given drugs for prophylaxis and mild self limiting disorders, when the risk from the disease is small or remote, and the risks of the therapy then loom larger in comparison. Certainly the risk perceptions of patients are enormously variable and certainly influenced by the disease they have. 

For the most part, ethosuximide is a safe drug. Most of the side effects are dose related and consist of nausea, gastrointestinal irritation, drowsiness, and anorexia. A variety of blood dyscrasias have been reported, but serious blood disorders are quite rare. 

Codeine, which is an opium alkaloid is most commonly opiate used as antitussive and more selective for cough centre. Like morphine, it depresses cough centre but is less constipating and abuse liability is low. It is relatively safe drug used in cough along with analgesic property and it s only important adverse effect is constipation. 

These drugs act to increase the volume of stool by absorbing water and as a result softening of faeces occurs. These are safe drugs (except in patient with strictures when intestinal obstruction may be precipitated). Adequate hydration of the patient is to be maintained. The onset of action occurs in 12-24 hours after oral intake. 

The penicillins are nontoxic and remarkably safe drug. The hypersensitivity reaction leading to anaphylaxis is only major problem which is seen in approximately 5 to 10% of the patients taking penicillin. 

Pyrimethamine is a safe drug and cause only nausea, vomiting, skin reaction e.g. skin rash, pruritus and higher dose can cause megaloblastic anaemia and granulocytopenia. 

Opioids, such as morphine and fentanyl, are safe, whereas there is insufficient data on some other analgesics to be sure of their position. All muscle relaxants are probably safe, although there are insufficient data about most to be completely sure atropine and neostigmine are safe. Drugs which are unsafe or probably unsafe include barbiturates, etomidate, enflurane, alcuronium, mepivacaine, pentazocine, some benzodiazepines (temazepam is safe, other benzodiazepines less certain), calcium channel blockers and aminophylline. 

At higher concentrations, atropine causes block of all parasympathetic functions. However, atropine is a remarkably safe drug in adults. Atropine poisoning has occurred as a result of attempted suicide, but most cases are due to attempts to induce hallucinations. 

H2 antagonists are extremely safe drugs. Adverse effects occur in less than 3% of patients and include diarrhea, headache, fatigue, myalgias, and constipation. Some studies suggest that intravenous H2 antagonists (or proton pump inhibitors) may increase the risk of nosocomial pneumonia in critically ill patients. 

APAP, although a safe drug in therapeutic doses, can lead to severe and potentially lethal liver and kidney injury in cases of overdose. Liver injury involves a characteristic centrilobular hepatic necrosis. The centrilobular region is rich in metabolic enzymes, such as the CYP family of isozymes. CYP2E1 is the predominant P450 isozyme in catalyzing the oxidation of APAP to a reactive intermediate, N-acetyl-p-benzoquinonimine (NAPQI), which possesses an electrophilic carbon that will covalently bind to cellular proteins [35], as shown in Scheme 3.2. 

In the present context, the term safe drug on the one hand includes the properties of a pharmaceutical related to its effectiveness, efficacy, and absence of unwanted side effects. On the other hand, the desired effects for its use, such as stability and biological activity, will be likely to have undesired consequences if the molecule enters the environment. This conflict can only be resolved if either the API compounds are not allowed to enter the environment, or they can quickly disintegrate... 

Designing Environmentally Safe Drugs 267 Table 9.2 Chemical functionalities and their impact on biodegradability [124]. 

---